Viimane versioon :
08/05/2024
Infostab
Ingredientide nimekiri
Nimekiri
Sobivus otsing
Y-liini sobivuse tabel
Viited
Uurimisrühmad
Valistab
Plakat
Sidemed
Sponsorid
Autor
Kasutusjuhend
Ajakiri
Amsacrine
Keemiline struktuur
Kaubanduslikud nimed erinevates maades
Preparaatide nimed on näitlikud ja abianete sisaldus võib erineda sõltuvalt riigist ja laborist
Amekrin
Norra, Rootsi, Soome, Taani
Amsa PD
Kanada
Amsalyo
Prantsusmaa
Amsidine
Austraalia, Belgia, Holland, Itaalia
Amsidyl
Saksamaa, Sveits
Viited : Amsacrine
Tüüp
Avaldamine
182
Ajaleht
Trissel LA, Gilbert DL, Martinez JF.
Compatibility of granisetron hydrochloride with selected drugs during simulated Y-site administration.
Am J Health-Syst Pharm 1997 ; 54: 56-60.
253
Ajaleht
Trissel LA, Chandler SW, Folstad JT.
Visual compatibility of amsacrine with selected drugs during simulated Y-site injection.
Am J Hosp Pharm 1990 ; 47: 2525-2528.
334
Ajaleht
Trissel LA, Tramonte SM, Grilley BJ.
Visual compatibility of ondansetron hydrochloride with selected drugs during simulated Y-site injection.
Am J Hosp Pharm 1991 ; 48: 988-992.
335
Ajaleht
Trissel LA, Bready BB, Kwan JW, Santiago NM.
Visual compatibility of sargramostim with selected antineoplasic agents, anti-infectives, or other drugs during simulated Y-site injection.
Am J Hosp Pharm 1992 ; 49: 402-406.
492
Ajaleht
Trissel LA, Parks NPT, Santiago NM.
Visual compatibility of fludarabine phosphate with antineoplastic drugs, anti-infectives, and other selected drugs during simulated Y-site injection.
Am J Hosp Pharm 1991 ; 48: 2186-2189.
829
Ajaleht
Cartwright-Shamoon JM, McElnay JC, D'Arcy PF.
Examination of sorption and photodegradation of amsacrine during storage in intravenous burette administration sets.
Int J Pharm 1988 ; 42: 41-46.
3523
Labor
Ceftriaxone (Rocephin®) - Summary of Product Characteristics.
Roche 2018
3576
Labor
Amsacrine (Amsalyo®) - Résumé des caractéristiques du produit
Prostrakan 2012
3595
Labor
Aciclovir - Summary of Product Characteristics
Hospira 2009
3745
Ajaleht
Kuenhle C, Moore
Sodium chloride residue provides potential for drug incompatibiities.
Am J Hosp Pharm 1979 ; 36: 881.
Mentions Légales
